Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant <i>Pseudomonas aeruginosa</i> ventriculitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis

Published:2022-02-24 Issue:6 Volume:77 Page:1787-1789
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Luque-Paz David¹²^ORCID,Bennis Youssef³^ORCID,Jaubert Paul¹,Dubée Vincent⁴,Wolff Michel⁵,Mortaza Satar¹

Affiliation:

1. Medical ICU, University Hospital of Angers, University of Angers , Angers, France

2. Infectious Diseases and Intensive Care Unit, Pontchaillou Hospital, University Hospital of Rennes , Rennes, France

3. Department of Clinical Pharmacology, Amiens University Medical Center , Amiens, France

4. Department of infectious diseases, University Hospital of Angers , Angers, France

5. Neurosurgical Intensive Care Unit, Saint-Anne Hospital, GHU Paris Psychiatrie & Neurosciences , Paris, France

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

https://academic.oup.com/jac/article-pdf/77/6/1787/43893421/dkac066.pdf

Reference8 articles.

1. 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis;Tunkel;Clin Infect Dis,2017

2. Nosocomial bacterial meningitis;van de Beek;N Engl J Med,2010

3. Ventriculitis: A severe complication of central nervous system infections;Luque-Paz;Open Forum Infect Dis,2021

4. Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial;Wunderink;Lancet Infect Dis,2020

5. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial;Bassetti;Lancet Infect Dis,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ventriculitis por Pseudomonas aeruginosa multirresistente (MDR) asociada a drenaje ventricular externo;Medicina Clínica;2024-08

2. Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed to improve the outcome of post‐neurosurgical extensively/multidrug‐resistant Gram‐negative bacteria‐related meningitis/ventriculitis in the current era of novel beta‐lactams and beta‐lactam/beta‐lactamase inhibitor combinations?;International Journal of Antimicrobial Agents;2024-06

3. Tackling the threat of antimicrobial resistance in neonates and children: outcomes from the first WHO-convened Paediatric Drug Optimisation exercise for antibiotics;The Lancet Child & Adolescent Health;2024-06

4. Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art;Antibiotics;2024-05-16

5. Case report: Successful treatment of OXA-23 Acinetobacter baumannii neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy;Frontiers in Medicine;2024-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3